EP0737077A1 - Hepatocyt gerichtete Arzneimittelkonjugate - Google Patents

Hepatocyt gerichtete Arzneimittelkonjugate

Info

Publication number
EP0737077A1
EP0737077A1 EP95908490A EP95908490A EP0737077A1 EP 0737077 A1 EP0737077 A1 EP 0737077A1 EP 95908490 A EP95908490 A EP 95908490A EP 95908490 A EP95908490 A EP 95908490A EP 0737077 A1 EP0737077 A1 EP 0737077A1
Authority
EP
European Patent Office
Prior art keywords
conjugate
crosslinker
ligand
covalently bonded
carrier molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95908490A
Other languages
English (en)
French (fr)
Inventor
Robert Plourde, Jr.
Ellen Carmichael
George L. Spitalny
Mark A. Findeis
Michael F. Ernst
Brett Robinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TargeTech Inc
Original Assignee
TargeTech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TargeTech Inc filed Critical TargeTech Inc
Publication of EP0737077A1 publication Critical patent/EP0737077A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP95908490A 1994-01-11 1995-01-11 Hepatocyt gerichtete Arzneimittelkonjugate Withdrawn EP0737077A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18020794A 1994-01-11 1994-01-11
US180207 1994-01-11
PCT/US1995/000448 WO1995018636A2 (en) 1994-01-11 1995-01-11 Hepatocyte-targeted drug conjugates

Publications (1)

Publication Number Publication Date
EP0737077A1 true EP0737077A1 (de) 1996-10-16

Family

ID=22659615

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95908490A Withdrawn EP0737077A1 (de) 1994-01-11 1995-01-11 Hepatocyt gerichtete Arzneimittelkonjugate

Country Status (5)

Country Link
EP (1) EP0737077A1 (de)
JP (1) JPH09510696A (de)
AU (1) AU1679195A (de)
CA (1) CA2180348A1 (de)
WO (1) WO1995018636A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6296844B1 (en) 1995-09-27 2001-10-02 The General Hospital Corporation Asialocytokines and treatment of liver disease
US5981507A (en) * 1995-12-14 1999-11-09 Advanced Magnetics, Inc. Polymeric carriers linked to nucleotide analogues via a phosphoramide bond
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
JP5750209B2 (ja) * 2007-03-16 2015-07-15 アプタ バイオサイエンス リミテッド 機能性分子、機能性分子合成用アミダイド、及び標的物質解析方法
WO2011086143A2 (en) * 2010-01-14 2011-07-21 Glaxo Group Limited Liver targeting molecules
JP5849336B2 (ja) * 2010-10-27 2016-01-27 公立大学法人横浜市立大学 アデニル酸シクラーゼの活性調節剤
US11058701B2 (en) 2015-12-03 2021-07-13 Biosight Ltd. Cytarabine conjugates for cancer therapy
AU2016362239B2 (en) 2015-12-03 2021-03-25 BioCytara Ltd. Salts of conjugates for cancer therapy
US12071450B2 (en) 2015-12-03 2024-08-27 Biosight Ltd. Salts of conjugates for cancer therapy
US12064445B2 (en) 2015-12-03 2024-08-20 Biosight Ltd. Cytarabine conjugates for cancer therapy
CN108610384B (zh) * 2018-05-31 2022-02-22 沈阳药科大学 基于肠道mct1载体蛋白设计的前药及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0538268A4 (en) * 1990-05-11 1993-05-12 The University Of Connecticut Targeted protection from cytotoxins
US5656609A (en) * 1992-09-24 1997-08-12 University Of Connecticut Method of enhancing and/or prolonging expression of gene introduced into a cell using colchicine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9518636A2 *

Also Published As

Publication number Publication date
WO1995018636A3 (en) 1995-08-10
AU1679195A (en) 1995-08-01
WO1995018636A2 (en) 1995-07-13
CA2180348A1 (en) 1995-07-13
JPH09510696A (ja) 1997-10-28

Similar Documents

Publication Publication Date Title
US5981507A (en) Polymeric carriers linked to nucleotide analogues via a phosphoramide bond
Di Stefano et al. A novel method for coupling doxorubicin to lactosaminated human albumin by an acid sensitive hydrazone bond: synthesis, characterization and preliminary biological properties of the conjugate
US6083926A (en) Water soluble vitamin B12 receptor modulating agents and methods related thereto
US5106951A (en) Antibody conjugates
ES2245805T3 (es) Polisacaridos que forman iminas, preparacion de los mismos y el uso de los mismos como adyuvantes de inmunoestimulantes.
Nishikawa et al. Synthesis and pharmacokinetics of a new liver-specific carrier, glycosylated carboxymethyl-dextran, and its application to drug targeting
US20050250679A1 (en) Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use
US20030119724A1 (en) Ligands to enhance cellular uptake of biomolecules
WO2000074721A1 (en) Vitamin directed dual targeting therapy
WO1988009823A1 (en) Amine derivatives of anthracycline antibiotics and antibody conjugates thereof
EP0737077A1 (de) Hepatocyt gerichtete Arzneimittelkonjugate
US20120213732A1 (en) Targeted delivery of antiviral compounds through hemoglobin bioconjugates
Fiume et al. Targeting of antiviral drugs to the liver using glycoprotein carriers
Di Stefano et al. Selective delivery to the liver of antiviral nucleoside analogs coupled to a high molecular mass lactosaminated poly-L-lysine and administered to mice by intramuscular route
Di Stefano et al. Doxorubicin coupled to lactosaminated human albumin remains confined within mouse liver cells after the intracellular release from the carrier
US20030103934A1 (en) Drugs having long-term retention in target tissue
WO1997014711A9 (en) Vitamin b12 receptor modulating agents and methods related thereto
Fiume et al. Targeting of antiviral drugs by coupling with protein carriers
US20080260691A1 (en) Prodrugs of Ribavirin with Improved Hepatic Delivery
Wu et al. A new N-acetylgalactosamine containing peptide as a targeting vehicle for mammalian hepatocytes via asialoglycoprotein receptor endocytosis
US20050220754A1 (en) Vitamin directed targeting therapy
JPH0633320B2 (ja) ラクトサミン化ヒトアルブミンとアデニン―９―β―Ｄ―アラビノフラノシド５′モノホスフェートの結合体の製造方法
CA2566874C (en) Targeted delivery of anti-viral compounds through hemoglobin bioconjugation
US6291638B1 (en) Hepatotropic conjugates of antiviral drugs carriers thereof and pharmaceutical compositions containing them
JPH01211530A (ja) 抗腫瘍剤

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960802

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19991102